The questions of whether ghrelin plays an important role in the pathogenesis of GERD and its associated complications of BE and esophageal adenocarcinoma and whether similar therapeutic approaches with a selective ghrelin receptor agonist could be applied in the management of GERD deserves further investigation. The gene discussed is GHRL; the disease is gastroesophageal reflux disease.